Published in BMC Ophthalmol on March 05, 2016
[Revision after filtration surgery]. Ophthalmologe (2016) 0.75
Statistical methods for assessing observer variability in clinical measures. BMJ (1992) 6.24
Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology (1991) 2.41
Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology (2008) 2.20
Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol (1991) 1.91
Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology (1992) 1.68
Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale. J Glaucoma (2003) 1.64
A review of trabeculectomy in East Asian people--the influence of race. Eye (Lond) (2005) 1.63
Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol (1998) 1.54
Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci (1998) 1.46
Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev (2005) 1.41
Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology (2008) 1.36
A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye (Lond) (2010) 1.30
Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? Br J Ophthalmol (1994) 1.29
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial. Eye (Lond) (2011) 1.28
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol (2006) 1.27
Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol (2009) 1.23
Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies. Graefes Arch Clin Exp Ophthalmol (2003) 1.23
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. Ophthalmology (2002) 1.20
Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma (2004) 1.16
Safe trabeculectomy technique: long term outcome. Br J Ophthalmol (2006) 1.16
Evaluation of trabeculectomy blebs using 3-dimensional cornea and anterior segment optical coherence tomography. Ophthalmology (2009) 1.16
Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C. J Glaucoma (2013) 1.08
Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Indian J Ophthalmol (2013) 1.07
Deep sclerectomy augmented with mitomycin C. Eye (Lond) (2005) 1.06
Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. J Ocul Pharmacol Ther (2012) 1.04
Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. J Glaucoma (2014) 1.03
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica (2008) 1.01
Comparison of two clinical Bleb grading systems. Ophthalmology (2006) 0.99
Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants. Br J Ophthalmol (2010) 0.98
Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy. J Glaucoma (2013) 0.98
Subconjunctival sodium hyaluronate 2.3% in trabeculectomy: a prospective randomized clinical trial. Ophthalmology (2006) 0.97
Incidence and management of cataract after glaucoma surgery. Curr Opin Ophthalmol (2013) 0.97
New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery. Curr Opin Pharmacol (2012) 0.93
Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis. PLoS One (2014) 0.90
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol (2007) 0.90
Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology (2013) 0.90
Focal pressure: a new method to encourage filtration after trabeculectomy. Ophthalmic Surg (1984) 0.89
The moorfields safer surgery system. Middle East Afr J Ophthalmol (2009) 0.88
High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment. Clin Experiment Ophthalmol (2009) 0.88
Efficacy and tolerability of nonpenetrating glaucoma surgery augmented with mitomycin C in treatment of open-angle glaucoma: a meta-analysis. Can J Ophthalmol (2009) 0.87
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. Clin Experiment Ophthalmol (2013) 0.87
Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C. Ophthalmologica (2005) 0.87